🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Autoimmune Encephalitis

Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases NCT06939166EARLY Phase 11 site📍 Tianjin Tianjin Huanhu Hospital · Tests: UCAR T-cell Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism NCT06079294NA1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: FDG PET Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes NCT05772611n/a1 site📍 Lyon Hospices Civils de Lyon · Tests: Genetic and immunology tests Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune Encephalitis NCT07477015n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis NCT04421846NA1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Blood sampling, cerebrospinal fluid , post-mortem cerebral tissues (NA for the Group 3), Blood sampling, cerebrospinal … High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Immune Cell Network NCT06863974NA8 sites📍 Angers📍 Brest📍 Le Kremlin-Bicêtre University Hospital, Angers · Tests: Blood test Cohort Study on Neuroimmune Diseases in the Reproductive Age NCT07653984n/a1 site📍 Guangzhou Third Affiliated Hospital, Sun Yat-Sen University Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis) NCT06584045NA1 site📍 Wuhan Tongji Hospital · Tests: Calculus bovis sativus (CBS) Long-term Impact of NMDAR Encephalitis, Level 3 NCT07158229n/a1 site📍 Bron Hospices Civils de Lyon · Tests: Questionnaires Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research NCT04806620n/a1 site📍 Delafield Brain Inflammation Collaborative OPM- MEG in Non-immune And iMmune-medIated Neurological Disease NCT07689682NA2 sites📍 Birmingham📍 Birmingham Aston University · Tests: OPM- Magnetoencephalography Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy NCT05849467Phase 11 site📍 Bethesda National Institute of Neurological Disorders and Stroke (NI… · Tests: 89 Zr-Df-crefmirlimab A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease NCT07093333Phase 21 site📍 Seoul Arialys Australia Pty Ltd · Tests: ART5803, ART5803-Cohort D CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases NCT07337785EARLY Phase 11 site📍 Wuhan Tongji Hospital · Tests: CD19/BCMA-targeted CAR-T cells, Lymphodepleting Conditioning Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis NCT06510283Phase 21 site📍 Beijing Beijing Tongren Hospital · Tests: Taitacept Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis NCT03993262Phase 217 sites📍 München📍 Würzburg📍 Jena Jena University Hospital · Tests: Bortezomib, Placebo A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis NCT06173076n/a1 site📍 Hangzhou Shen Chun-Hong Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis NCT06867991Phase 32 sites📍 Zhengzhou📍 Changzhou The First People's Hospital of Changzhou · Tests: Ofatumumab combined with daratumumab, Ofatumumab, Repeated intravenous immunoglobulin/plasma exchange therapy Natural History Study of Progressive Multifocal Leukoencephalopathy (PML) NCT01730131n/a1 site📍 Bethesda National Institute of Neurological Disorders and Stroke (NI… Medium-term Effects of Treatments in Autoimmune Encephalitis NCT07133113n/a1 site📍 Bron Hospices Civils de Lyon · Tests: We aim to assess the clinical response to the treatment initiation protocols most commonly used in autoimmune encephali… Collection of Biological Samples From Patients With Rare Neurological Diseases NCT04698421n/a1 site📍 Toulouse University Hospital, Toulouse · Tests: Blood collection on admission and longitudinally Efgartigimod in Anti-NMDA Receptor Encephalitis. NCT07822776Phase 21 site📍 Beijing Beijing Tongren Hospital · Tests: Efgartigimod Alfa FDG-PET in the Diagnosis of Autoimmune Encephalitis NCT06019975n/a6 sites📍 Udine📍 Genoa📍 Pavia University of Milano Bicocca · Tests: FDG-PET Plasma Exchange in Pediatric Autoimmune Encephalitis NCT07707739NA1 site📍 Shibīn al Kawm Menoufia University · Tests: Plasma exchange (PE), Plasma exchange (PE) Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System NCT04561557EARLY Phase 11 site📍 Wuhan Tongji Hospital · Tests: CT103A cells, Cyclophosphamide and fludarabine Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia NCT07732907n/a1 site📍 Lawrenceville Bristol-Myers Squibb · Tests: Ozanimod Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases. NCT07526493Phase 11 site📍 Wuhan Tongji Hospital · Tests: Universal CD19 CAR-γδT Cell Injection, Cyclophosphamide, Fludarabine Lupus Landmark Study: A Prospective Registry and Biorepository NCT05934149n/a25 sites📍 Birmingham📍 Tucson📍 Beverly Hills Lupus Research Alliance Biomarkers in Autoimmune Disease of Nervous System NCT06502015n/a1 site📍 Wuhan Tongji Hospital · Tests: biomaker levels Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the Disease NCT06515106NA1 site📍 Barcelona Fundacion Clinic per a la Recerca Biomédica · Tests: Remote cognitive rehabilitation program
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy